Drug Interactions between Cardiolite and Lexiscan
This report displays the potential drug interactions for the following 2 drugs:
- Cardiolite (sestamibi)
- Lexiscan (regadenoson)
Interactions between your drugs
No interactions were found between Cardiolite and Lexiscan. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
A total of 0 drugs are known to interact with Cardiolite.
- Cardiolite is in the drug class radiologic conjugating agents.
- Cardiolite is used to treat Diagnosis and Investigation.
- Lexiscan is in the drug class cardiac stressing agents.
- Lexiscan is used to treat the following conditions:
Drug and food interactions
Applies to: Lexiscan (regadenoson)
Caffeine may interfere with the effects of regadenoson. You should avoid caffeine-containing products for at least 12 hours before an imaging procedure involving regadenoson.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
|No interaction information available.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.